<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou LH</submitter><funding>Key Clinical Frontier Technology Project of the Department of Science and Technology of Jiangsu</funding><funding>Innovative Research Group Project of the National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China</funding><pagination>e05820</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12767070</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>The neonatal heart possesses the unique ability to regenerate post-injury. Underlying related mechanisms and reactivation of this process are crucial for regeneration medicine. Using quantitative proteomics with tandem mass tag labeling, RNA-sequencing (RNA-seq) and single-nucleus RNA-seq dataset analyses, high mobility group box 2 (HMGB2) is identified as a key regulator of cardiomyocyte proliferation, whose expression declines during postnatal heart development and increases in the high regenerative potential cardiomyocyte populations in hearts post-injury. Cardiomyocyte-specific HMGB2 knockdown curtails cardiomyocyte proliferation and impairs heart regeneration following apical resection in neonatal mice, while cardiomyocyte-specific HMGB2 overexpression enhances cardiomyocyte prolifera</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>HMGB2 Promotes Cardiomyocyte Proliferation and Heart Regeneration Through MTA2-Driven Metabolic Reprogramming.</pubmed_title><pmcid>PMC12767070</pmcid><funding_grant_id>BE2022806</funding_grant_id><funding_grant_id>82121001</funding_grant_id><funding_grant_id>82370344</funding_grant_id><pubmed_authors>Zhang XZ</pubmed_authors><pubmed_authors>Wang LS</pubmed_authors><pubmed_authors>Jing P</pubmed_authors><pubmed_authors>Chen YX</pubmed_authors><pubmed_authors>Bao YL</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Wang SB</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Xie LP</pubmed_authors><pubmed_authors>Yang TT</pubmed_authors><pubmed_authors>Zhou LH</pubmed_authors><pubmed_authors>Gu LF</pubmed_authors><pubmed_authors>Shan TK</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Du C</pubmed_authors><pubmed_authors>Wang QM</pubmed_authors><pubmed_authors>Chen JY</pubmed_authors><pubmed_authors>Ji Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>HMGB2 Promotes Cardiomyocyte Proliferation and Heart Regeneration Through MTA2-Driven Metabolic Reprogramming.</name><description>The neonatal heart possesses the unique ability to regenerate post-injury. Underlying related mechanisms and reactivation of this process are crucial for regeneration medicine. Using quantitative proteomics with tandem mass tag labeling, RNA-sequencing (RNA-seq) and single-nucleus RNA-seq dataset analyses, high mobility group box 2 (HMGB2) is identified as a key regulator of cardiomyocyte proliferation, whose expression declines during postnatal heart development and increases in the high regenerative potential cardiomyocyte populations in hearts post-injury. Cardiomyocyte-specific HMGB2 knockdown curtails cardiomyocyte proliferation and impairs heart regeneration following apical resection in neonatal mice, while cardiomyocyte-specific HMGB2 overexpression enhances cardiomyocyte prolifera</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T11:05:35.84Z</modification><creation>2026-05-29T03:13:02.431Z</creation></dates><accession>S-EPMC12767070</accession><cross_references><pubmed>41092376</pubmed><doi>10.1002/advs.202505820</doi></cross_references></HashMap>